Clinical trial NCT01770210 - References

Cardiovascular Disorders — Ekvasis of Atorvastatin (Antorcin®) Treatment in Patients With Acute Cardiovascular Events

Citation(s)

•   Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J
  Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002 Jul 24-31;288(4):455-61.
•   Davidson MH
  Clinical significance of statin pleiotropic effects: hypotheses versus evidence. Circulation. 2005 May 10;111(18):2280-1. Erratum in: Circulation. 2005 Aug 30;112(9):e126.
•   Frolkis JP, Pearce GL, Nambi V, Minor S, Sprecher DL
  Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice. Am J Med. 2002 Dec 1;113(8):625-9.
•   Guidelines of the Hellenic Society of Atherosclerosis for the diagnosis and treatment of dyslipidemia M
  Elisaf, Ch. Pitsavos, E. Liberopoulos, V. Athyros Hellenic Journal of Atherosclerosis 2(3):163-168, 06/04/2011
•   Heeschen C, Hamm CW, Laufs U, Snapinn S, Böhm M, White HD; Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators
  Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation. 2002 Mar 26;105(12):1446-52.
•   Jackevicius CA, Mamdani M, Tu JV
  Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002 Jul 24-31;288(4):462-7.
•   Larsen J, Andersen M, Kragstrup J, Gram LF
  High persistence of statin use in a Danish population: compliance study 1993-1998. Br J Clin Pharmacol. 2002 Apr;53(4):375-8.
•   Miettinen TA, Pyörälä K, Olsson AG, Musliner TA, Cook TJ, Faergeman O, Berg K, Pedersen T, Kjekshus J
  Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S). Circulation. 1997 Dec 16;96(12):4211-8.
•   S Carter D Taylor
  A Question of Choice: Compliance in Medicine Taking. Medicines Partnership 2003, www.medicines-partnership.org
•   Seiki S, Frishman WH
  Pharmacologic inhibition of squalene synthase and other downstream enzymes of the cholesterol synthesis pathway: a new therapeutic approach to treatment of hypercholesterolemia. Cardiol Rev. 2009 Mar-Apr;17(2):70-6. doi: 10.1097/CRD.0b013e3181885905. Review.
•   Simons LA, Levis G, Simons J
  Apparent discontinuation rates in patients prescribed lipid-lowering drugs. Med J Aust. 1996 Feb 19;164(4):208-11.
•   Thomas M, Mann J
  Increased thrombotic vascular events after change of statin. Lancet. 1998 Dec 5;352(9143):1830-1.
•   Thomas T, Ginsberg H
  Development of apolipoprotein B antisense molecules as a therapy for hyperlipidemia. Curr Atheroscler Rep. 2010 Jan;12(1):58-65. doi: 10.1007/s11883-009-0078-7. Review.
•   Wei L, Wang J, Thompson P, Wong S, Struthers AD, MacDonald TM
  Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart. 2002 Sep;88(3):229-33.

A Multicenter, Open-label, 30-week Observational Clinical Study to Examine the Progress of Patients After Leaving the Cardiology Clinic or Unit Due to Acute Cardiovascular Event.

Details for clinical trial NCT01770210